Matèria: Medicina
Drets d'accés: info:eu-repo/semantics/openAccess
Identificador del investigador: 0000-0001-5906-5632
Publicat per (editora): Universitat Rovira i Virgili (URV)
Publicacions relacionades: Pérez-Lacasta, M. J., Martínez-Alonso, M., Garcia, M., Sala, M., Perestelo-Pérez, L., Vidal, C., Codern-Bové, N., Feijoo-Cid, M., Toledo-Chávarri, A., Cardona, À., Pons, A., Carles-Lavila, M., Rue, M., & with the InforMa Group. (2019). Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLOS ONE, 14(3), e0214057. https://doi.org/10.1371/journal.pone.0214057
Resum: In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision making outcomes, in women approaching the age of invitation to mammography screening.
Departament: Economia
DOI: 10.5061/dryad.ft0207r
Tipus de document: info:eu-repo/semantics/other
DOI de la publicació relacionada: 10.1371/journal.pone.0214057
Data alta repositori: 2022-09-19
Autor: Pérez-Lacasta, M.
Paraules clau: Breast cancer, Medical and health sciences, Decision aids, early detection, Informed choice, Screening
Grup de recerca: ECONOMIC CHALLENGES FOR THE NEXT GENERATION RESEARCH GROUP
Any de publicació de la dataset: 2022
Acció del programa de finançament: Instituto de Salud Carlos III, Award: PI14/00113
Títol del conjunt de dades: Data from: Effect of information about the benefits and harms of mammography on women's decision making: the InforMa randomised controlled trial